title: Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine.
authors.forename: Paolo
authors.initials: P
authors.lastname: Bernasconi
authors.forename: Marco
authors.initials: M
authors.lastname: Paulli
authors.forename: Ester
authors.initials: E
authors.lastname: Orlandi
authors.forename: Vittorio
authors.initials: V
authors.lastname: Perfetti
authors.forename: Ilaria
authors.initials: I
authors.lastname: Giardini
authors.forename: Silvia
authors.initials: S
authors.lastname: Zibellini
authors.forename: Laura
authors.initials: L
authors.lastname: Vanelli
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Tenore
authors.forename: Alessandra
authors.initials: A
authors.lastname: Algarotti
authors.forename: Marina
authors.initials: M
authors.lastname: Boni
authors.forename: Mara
authors.initials: M
authors.lastname: De Amici
authors.forename: Ercole
authors.initials: E
authors.lastname: Brusamolino
authors.forename: Mario
authors.initials: M
authors.lastname: Lazzarino
mesh_terms: D002471:Cell Transformation, Neoplastic; D005260:Female; D005803:Genes, Immunoglobulin; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse; D008875:Middle Aged; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D014740:Vidarabine; C024352:fludarabine